Published in Am J Gastroenterol on October 11, 2016
The Low FODMAP Diet: Many Question Marks for a Catchy Acronym. Nutrients (2017) 0.78
Controversies and Recent Developments of the Low-FODMAP Diet. Gastroenterol Hepatol (N Y) (2017) 0.75
Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice. United European Gastroenterol J (2017) 0.75
Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients (2017) 0.75
Western Dietary Pattern Is Associated with Irritable Bowel Syndrome in the French NutriNet Cohort. Nutrients (2017) 0.75
Behavioral gastroenterology: An emerging system and new frontier of action. World J Gastroenterol (2017) 0.75
Functional bowel disorders. Gastroenterology (2006) 20.72
Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med (2011) 10.03
The functional gastrointestinal disorders and the Rome III process. Gastroenterology (2006) 8.71
A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology (2013) 8.37
A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med (2001) 3.05
A review of validations of dietary assessment methods. Am J Epidemiol (1982) 2.92
Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial. Gastroenterology (2015) 2.85
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol (2010) 2.52
Comparative advantage of 3-day food records over 24-hour recall and 5-day food frequency validated by observation of 9- and 10-year-old girls. J Am Diet Assoc (1994) 2.30
Irritable bowel syndrome: a clinical review. JAMA (2015) 2.26
Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther (2004) 1.92
Eluxadoline for Irritable Bowel Syndrome with Diarrhea. N Engl J Med (2016) 1.82
Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet (2011) 1.68
Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut (2014) 1.54
Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics (2006) 1.53
Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr (2012) 1.51
The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract (2013) 1.37
Issues in reproducibility and validity of dietary studies. Am J Clin Nutr (1989) 1.37
What patients know about irritable bowel syndrome (IBS) and what they would like to know. National Survey on Patient Educational Needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ). Am J Gastroenterol (2007) 1.29
Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther (2010) 1.24
Food hypersensitivity in irritable bowel syndrome. Lancet (1983) 1.24
Irritable bowel syndrome and hypersensitivity to food. Ann Allergy (1985) 1.20
Food: the forgotten factor in the irritable bowel syndrome. Gastroenterol Clin North Am (2011) 1.15
Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol (2004) 1.15
Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women. Am J Gastroenterol (2002) 1.08
FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut (2016) 0.97
Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome. Mol Med Rep (2013) 0.94
Food allergy and the irritable bowel syndrome. Am J Gastroenterol (1988) 0.79
A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Am J Gastroenterol (2015) 2.35
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol (2017) 1.11
How Do US Gastroenterologists Use Over-the-Counter and Prescription Medications in Patients With Gastroesophageal Reflux and Chronic Constipation? Am J Gastroenterol (2015) 0.76
Response to Sorrentino et al. Am J Gastroenterol (2015) 0.75
The Light Shines on: American Journal of Gastroenterology 2015. Am J Gastroenterol (2015) 0.75
Introduction. J Gastroenterol Hepatol (2017) 0.75
Response to Georgopoulos et al. Am J Gastroenterol (2017) 0.75